JP2019516104A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019516104A5 JP2019516104A5 JP2018557905A JP2018557905A JP2019516104A5 JP 2019516104 A5 JP2019516104 A5 JP 2019516104A5 JP 2018557905 A JP2018557905 A JP 2018557905A JP 2018557905 A JP2018557905 A JP 2018557905A JP 2019516104 A5 JP2019516104 A5 JP 2019516104A5
- Authority
- JP
- Japan
- Prior art keywords
- ldha
- expression level
- protein
- mmp9
- cadh1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023003700A JP7492287B2 (ja) | 2016-05-04 | 2023-01-13 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
| JP2024077227A JP7797770B2 (ja) | 2016-05-04 | 2024-05-10 | 子宮内膜がんのマーカーとしてのｋｐｙｍ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16168328.9 | 2016-05-04 | ||
| EP16168328 | 2016-05-04 | ||
| PCT/EP2017/057635 WO2017190896A1 (en) | 2016-05-04 | 2017-03-30 | Mmp9 as marker of endometrial cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023003700A Division JP7492287B2 (ja) | 2016-05-04 | 2023-01-13 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019516104A JP2019516104A (ja) | 2019-06-13 |
| JP2019516104A5 true JP2019516104A5 (enExample) | 2020-04-23 |
| JP7240712B2 JP7240712B2 (ja) | 2023-03-16 |
Family
ID=56096908
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557905A Active JP7240712B2 (ja) | 2016-05-04 | 2017-03-30 | 子宮内膜がんのマーカーとしてのｐｅｒｍ |
| JP2023003700A Active JP7492287B2 (ja) | 2016-05-04 | 2023-01-13 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
| JP2024077227A Active JP7797770B2 (ja) | 2016-05-04 | 2024-05-10 | 子宮内膜がんのマーカーとしてのｋｐｙｍ |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023003700A Active JP7492287B2 (ja) | 2016-05-04 | 2023-01-13 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
| JP2024077227A Active JP7797770B2 (ja) | 2016-05-04 | 2024-05-10 | 子宮内膜がんのマーカーとしてのｋｐｙｍ |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20190137499A1 (enExample) |
| EP (3) | EP4180814B1 (enExample) |
| JP (3) | JP7240712B2 (enExample) |
| AU (3) | AU2017260806B9 (enExample) |
| CA (2) | CA3022586A1 (enExample) |
| DK (1) | DK3452829T3 (enExample) |
| ES (1) | ES2974307T3 (enExample) |
| FI (1) | FI3452829T3 (enExample) |
| PL (1) | PL3452829T3 (enExample) |
| PT (1) | PT3452829T (enExample) |
| WO (1) | WO2017190896A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3655778T3 (pl) * | 2017-07-21 | 2023-09-18 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Agryna jako marker raka endometrium |
| AU2022315559A1 (en) * | 2021-07-23 | 2024-02-15 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Biomarkers for endometrial cancer |
| CN113493838B (zh) * | 2021-09-06 | 2021-11-23 | 北京泱深生物信息技术有限公司 | 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用 |
| KR102640230B1 (ko) * | 2021-09-24 | 2024-02-22 | 가천대학교 산학협력단 | C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| AUPO573697A0 (en) * | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
| EP1711618B1 (en) | 2003-12-23 | 2010-08-04 | Mount Sinai Hospital Corporation | Methods for detecting markers associated with endometrial disease or phase |
| US20080090258A1 (en) * | 2006-06-28 | 2008-04-17 | University Of Pittsburgh -Of The Commonwealth System Of Higher Education | Method and composition for diagnosing endometrial cancer |
| EP2087152B1 (en) | 2006-10-27 | 2015-03-11 | Walfish, Paul | Endometrial biomarkers |
| CA2767914C (en) * | 2009-07-24 | 2020-02-25 | Geadic Biotec, Aie. | Markers for endometrial cancer |
-
2017
- 2017-03-30 EP EP23150361.6A patent/EP4180814B1/en active Active
- 2017-03-30 PL PL17713973.0T patent/PL3452829T3/pl unknown
- 2017-03-30 ES ES17713973T patent/ES2974307T3/es active Active
- 2017-03-30 EP EP25190526.1A patent/EP4610655A3/en active Pending
- 2017-03-30 FI FIEP17713973.0T patent/FI3452829T3/fi active
- 2017-03-30 JP JP2018557905A patent/JP7240712B2/ja active Active
- 2017-03-30 DK DK17713973.0T patent/DK3452829T3/da active
- 2017-03-30 WO PCT/EP2017/057635 patent/WO2017190896A1/en not_active Ceased
- 2017-03-30 PT PT177139730T patent/PT3452829T/pt unknown
- 2017-03-30 CA CA3022586A patent/CA3022586A1/en active Pending
- 2017-03-30 CA CA3286798A patent/CA3286798A1/en active Pending
- 2017-03-30 AU AU2017260806A patent/AU2017260806B9/en active Active
- 2017-03-30 US US16/098,813 patent/US20190137499A1/en not_active Abandoned
- 2017-03-30 EP EP17713973.0A patent/EP3452829B1/en active Active
-
2022
- 2022-11-09 US US17/984,197 patent/US20230221323A1/en not_active Abandoned
-
2023
- 2023-01-13 JP JP2023003700A patent/JP7492287B2/ja active Active
- 2023-08-02 AU AU2023210591A patent/AU2023210591B9/en active Active
-
2024
- 2024-05-10 JP JP2024077227A patent/JP7797770B2/ja active Active
-
2025
- 2025-09-01 AU AU2025223935A patent/AU2025223935A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Steiner et al. | Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University | |
| López et al. | Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection | |
| Sandri et al. | Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome | |
| FI3655778T3 (fi) | Agriini endometriumsyövän markkerina | |
| HRP20190533T1 (hr) | Postupak za otkrivanje nukleosoma koji sadrže nukleotide | |
| WO2015176066A3 (en) | Lpa-associated protein and rna expression | |
| Kazakov et al. | Fibroadenoma and phyllodes tumors of anogenital mammary-like glands: a series of 13 neoplasms in 12 cases, including mammary-type juvenile fibroadenoma, fibroadenoma with lactation changes, and neurofibromatosis-associated pseudoangiomatous stromal hyperplasia with multinucleated giant cells | |
| JP2019500582A5 (enExample) | ||
| MX2018012580A (es) | Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia. | |
| JP2017184729A5 (enExample) | ||
| Shiozaki et al. | Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?: the remaining controversy and review of the literature | |
| Honing et al. | CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy | |
| US20190218619A1 (en) | Composition for diagnosing cancer using potassium channel proteins | |
| DK2054443T3 (da) | Antistoffer mod en epitop fra AGR2, assays og hybridomer | |
| Hanna et al. | Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma | |
| Takeda et al. | The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma | |
| CN104535766B (zh) | 外周血exosome来源的肝癌诊断和预后标志物及其应用 | |
| EP4610655A3 (en) | Markers of endometrial cancer | |
| JP2020512549A5 (enExample) | ||
| JP2017524933A5 (enExample) | ||
| RU2018123581A (ru) | Способ для выделения раковых стволовых клеток | |
| Guo et al. | Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance | |
| Chen et al. | A combined CRISP3 and SPINK1 prognostic grade in EPS-urine and establishment of models to predict prognosis of patients with prostate cancer | |
| KR102316178B1 (ko) | 난소암 환자의 암 재발율 또는 생존율 예측용 조성물 | |
| RU2017120228A (ru) | Особые моноклональные антитела антигена м метапневмовируса человека (hmpv) и способ их использования в методе диагностики |